CLASS I Drug recall · Reported 14 Feb 2018 · FDA Enforcement Report

Ampicillin and Sulbactam for Injection vial recalled by Aurobindo Pharma

Aurobindo Pharma is recalling Ampicillin and Sulbactam for Injection vial, sterile Dry Powder for injection, 10 vials, distributed nationwide in the US. The recall was initiated on 2 Jan 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot Number AF0117001-A
NDC55150-116, 55150-117, 55150-178, 55150-179
UPC0355150116201, 0355150179992, 0355150178995, 0355150117208
Quantity recalled53,040 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0339-2018
FDA event ID
78847
Recalling firm
Aurobindo Pharma, Hyderabad, N/A
Manufacturer
Eugia US LLC
Classification
Class I
Status
Terminated
Recall initiated
2 Jan 2018
FDA classified
8 Feb 2018
Reported
14 Feb 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

2 Jan 2018Recall initiated by company
8 Feb 2018Classified by FDA+37 days
14 Feb 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.

Product as listed by the FDA

Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Distributed by AuroMedics Pharma LLC. 279 Princeton-Highstown Rd. E. Windsor, NJ 08520, NDC 55150-116-20

Where it was distributed

distributed nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.

Which lots are affected?

Lot Number AF0117001-A

Where was it sold?

distributed nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Aurobindo Pharma

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIMetformin Hydrochloride Tablets, USP 1000 mg recalledMetformin HydrochlorideAurobindo PharmaOtherNationwide
DrugCLASS IINorthstar Zolpidem Tartrate Tablets USP 10 mg recalledAurobindo PharmaOtherNationwide

Other Ampicillin recalls

All 31